a doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.

Christina Apfelthaler; Katharina Skoll; Raphaela Ciola; Franz Gabor; Michael Wirth

a doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Pages (from-to)	177-184
Journal	European Journal of Pharmaceutical Sciences
Volume	130
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Austrian Fields of Science 2012

301208 Pharmaceutical technology

Cite this

@article{5cdfad08d8d34e1db9618378e2f264b9,

title = "a doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.",

author = "Christina Apfelthaler and Katharina Skoll and Raphaela Ciola and Franz Gabor and Michael Wirth",

year = "2018",

language = "English",

volume = "130",

pages = "177--184",

journal = "European Journal of Pharmaceutical Sciences",

issn = "0928-0987",

publisher = "Elsevier",

}

TY - JOUR

T1 - a doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.

AU - Apfelthaler, Christina

AU - Skoll, Katharina

AU - Ciola, Raphaela

AU - Gabor, Franz

AU - Wirth, Michael

PY - 2018

Y1 - 2018

M3 - Article

SN - 0928-0987

VL - 130

SP - 177

EP - 184

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

ER -